Sort   by:  
 Page size 
UnknownCoexistence of different circulating anti-podocyte antibodies in membranous nephropathy.
Not available
S-EPMC3430946 | biostudies-literature
UnknownAssociation of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis.
Not available
S-EPMC9269630 | biostudies-literature
UnknownImplementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).
Not available
S-EPMC10288779 | biostudies-literature
UnknownGenomics Integration Into Nephrology Practice.
Not available
S-EPMC8551494 | biostudies-literature
UnknownAcute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression.
Not available
S-EPMC8819983 | biostudies-literature
UnknownThe genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis.
Not available
S-EPMC7105485 | biostudies-literature
UnknownLongitudinal Changes in Health-Related Quality of Life in Primary Glomerular Disease: Results From the CureGN Study.
Not available
S-EPMC7569685 | biostudies-literature
UnknownClinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study.
Not available
S-EPMC6224619 | biostudies-literature
UnknownHealth-related quality of life in glomerular disease.
Not available
S-EPMC6743723 | biostudies-literature
UnknownCureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
Not available
S-EPMC6348011 | biostudies-literature
Sort   by:  
 Page size